Publicacions (50) Publicacions de FRANCISCO ALÉN FARIÑAS

2023

  1. Awake and Sleep Bruxism Prevalence and Their Associated Psychological Factors in First-Year University Students: A Pre-Mid-Post COVID-19 Pandemic Comparison

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3, pp. 2452

2022

  1. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

  2. Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors

    Neuropsychopharmacology, Vol. 47, Núm. 8, pp. 1449-1460

2021

  1. Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking

    Addiction Biology, Vol. 26, Núm. 3

  2. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

  3. Sex-specific behavioral and neurogenic responses to cocaine in mice lacking and blocking dopamine D1 or dopamine D2 receptors

    Journal of Comparative Neurology, Vol. 529, Núm. 8, pp. 1724-1742

  4. Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain

    Brain Structure and Function, Vol. 226, Núm. 7, pp. 2243-2264

2020

  1. Adaptive Stress Coping in Awake Bruxism

    Frontiers in Neurology, Vol. 11

  2. Antianhedonic and antidepressant effects of Affron® a standardized saffron (Crocus Sativus L.) extract

    Molecules, Vol. 25, Núm. 14

  3. Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala

    Addiction Biology, Vol. 25, Núm. 5

2019

  1. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats

    Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033

  2. Bupropion, a possible antidepressant without negative effects on alcohol relapse

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 756-765

  3. Oleoylethanolamide modulates BDNF-ERK signaling and neurogenesis in the hippocampi of rats exposed to δ9-THC and ethanol binge drinking during adolescence

    Frontiers in Molecular Neuroscience, Vol. 12

  4. Oleoylethanolamide, neuroinflammation, and alcohol abuse

    Frontiers in Molecular Neuroscience, Vol. 11

  5. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants

    Neuropharmacology, Vol. 149, pp. 212-220

  6. Rethinking the Use of Antidepressants to Treat Alcohol Use Disorders and Depression Comorbidity: The Role of Neurogenesis

    Antidepressants - Preclinical, Clinical and Translational Aspects

  7. Role of the galanin N-terminal fragment (1-15) in anhedonia: Involvement of the dopaminergic mesolimbic system

    Journal of Psychopharmacology, Vol. 33, Núm. 6, pp. 737-747

  8. Sex-Dimorphic Behavioral Alterations and Altered Neurogenesis in U12 Intron Splicing-Defective Zrsr1 Mutant Mice

    International Journal of Molecular Sciences, Vol. 20, Núm. 14

2018

  1. Impaired Spermatogenesis, Muscle, and Erythrocyte Function in U12 Intron Splicing-Defective Zrsr1 Mutant Mice

    Cell Reports, Vol. 23, Núm. 1, pp. 143-155

  2. Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women

    Addiction Biology, Vol. 23, Núm. 6, pp. 1242-1250